Market Cap (In NOK)
1.64 Billion
Revenue (In NOK)
500.65 Million
Net Income (In NOK)
979 Thousand
Avg. Volume
2783.00
- Currency
- NOK
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 40.85-71.9
- PE
- -
- EPS
- -
- Beta Value
- 0.988
- ISIN
- NO0010000045
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Mr. Daniel Schneider
- Employee Count
- -
- Website
- https://www.photocure.com
- Ipo Date
- 2011-01-14
- Details
- Photocure ASA, a specialty pharmaceutical company, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products in Nordic countries, Germany, France, Austria, the United Kingdom, the Netherlands, Italy, other European Countries, and the United States. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It also develops Cevira for the treatment of human papilloma virus infection and precancerous lesions of the cervix. The company sells its products to pharmaceutical wholesalers, pharmacies, and hospitals through license partners. Photocure ASA was founded in 1993 and is headquartered in Oslo, Norway.
More Stocks
-
LTNCLabor Smart, Inc.
LTNC
-
MOTOGENFINThe Motor & General Finance Limited
MOTOGENFIN
-
ALDV
-
NCK
-
3OY1
-
BLKBlackRock, Inc.
BLK
-
0QN1
-
603353